ANESTHESIA -HSPI

Optimizing Muscle Relaxant Selection in Pediatric Day Surgery Rocuronium vs Atracurium vs Cisatracurium

Introduction:

Pediatric day surgeries demand not only rapid induction and recovery but also precise neuromuscular control. This study investigates the comparative effectiveness and pharmacoeconomic rationale of three modern muscle relaxants rocuronium bromide, atracurium besilate, and cisatracurium besilateduring short surgical interventions in children. Conducted at the Azerbaijan Medical University, the research offers insights into choosing the most efficient and safest relaxant for specific age groups and surgical conditions.

Key Study Highlights and Findings

  • Study Design:
    • 156 children aged 0–16 years.
    • Divided into 3 main groups based on the muscle relaxant used.
    • Each group further divided by age (under 2 years and 2–16 years) and anesthesia type (sevoflurane + fentanyl or isoflurane + fentanyl).
  • Muscle Relaxants Compared:
    • Rocuronium bromide (Esmeron)
    • Atracurium besilate (Tracrium)
    • Cisatracurium besilate (Nimbex)
  • Evaluation Metrics:
    • Depth and onset of neuromuscular blockade.
    • Recovery times (T1 and TOF values).
    • Safety and side-effect profile.
    • Compatibility with sevoflurane and isoflurane anesthesia.
  • Key Findings:
    • Rocuronium showed the fastest onset, especially effective in children under 2 years.
    • Cisatracurium exhibited the greatest depth of blockade, ideal for laparoscopic or longer procedures.
    • Atracurium had the shortest recovery times and was most favorable for quicker extubation and turnover.

Clinical Implications in Pediatric Anesthesia

Choosing a muscle relaxant based on both pharmacodynamic profile and patient age significantly impacts surgical outcomes and operating room efficiency. For example, in shorter surgeries, atracurium’s rapid recovery may be ideal. In contrast, cisatracurium’s profound relaxation makes it preferable in cases requiring longer muscle flaccidity.

Anesthesia Protocol Integration and Journal Access

Call to Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.